Literature DB >> 24719243

Direct stenting is an independent predictor of improved survival in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction.

Liam M McCormick1, Adam J Brown1, Liam S Ring1, Parag R Gajendragadkar1, Seth J Dockrill2, Simon P Hansom2, Joel P Giblett1, Timothy J Gilbert2, Stephen P Hoole1, Nick E J West3.   

Abstract

AIMS: Randomised trials have shown that direct stenting (DS) is associated with improved markers of reperfusion during primary percutaneous coronary intervention (PPCI) for ST elevation myocardial infarction (STEMI). However, data evaluating its impact on long-term clinical outcomes are lacking. We set out to evaluate the effect of DS on mortality in a contemporary population of patients undergoing PPCI for STEMI.
METHODS: Consecutive patients undergoing PPCI for STEMI at two high-volume UK heart attack centres between September 2008- December 2010 (n=1562) were included in the analysis. Local databases were analysed for patient demographics, as well as details on PPCI strategy, including use of DS versus predilatation (PD) followed by stenting, manual thrombus aspiration (MT) and glycoprotein IIb/IIIa inhibitors (GPIs). National databases were interrogated for in-hospital, 30-day and one-year mortality. To determine the impact of PPCI strategy on one-year survival, multivariate logistic analysis was performed.
RESULTS: Altogether 489 patients underwent DS (31.3%) and 1073 (68.7%) received PD prior to stenting. Patients receiving DS had reduced mortality at 30 days (2.04 versus 4.66%, p=0.01) and one year (3.27 versus 8.48%, p=0.0001). After multivariate adjustment, PD remained an independent predictor of one-year mortality (odds ratio 2.42, 95% confidence interval 1.08-5.45, p=0.032) along with age, cardiogenic shock, number of diseased vessels, and left main or proximal left anterior descending artery intervention. However, neither GPI use nor MT improved survival in either univariate or multivariate analyses.
CONCLUSIONS: In a contemporary, unselected population of patients undergoing PPCI for STEMI, DS - when compared with stenting after PD - is independently predictive of improved 30-day and one-year survival. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Primary percutaneous coronary intervention; ST elevation myocardial infarction; direct stenting; mortality; predilatation

Mesh:

Year:  2014        PMID: 24719243     DOI: 10.1177/2048872614530864

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  5 in total

1.  Thrombus aspiration in primary percutaneous coronary intervention: still a valid option with improved technique in selected patients!

Authors:  Fabio Mangiacapra; Alessandro Sticchi; Emanuele Barbato
Journal:  Cardiovasc Diagn Ther       Date:  2017-06

2.  ST-elevation myocardial infarction, thrombus aspiration, and different invasive strategies. A TASTE trial substudy.

Authors:  Ole Fröbert; Fredrik Calais; Stefan K James; Bo Lagerqvist
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

3.  Impact of direct stenting on clinical outcomes for small vessel coronary artery disease in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Kahraman Cosansu; Cagin Mustafa Ureyen; Mehmet Bulent Vatan; Mustafa Tarik Agac; Harun Kilic; Ramazan Akdemir
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-12-08       Impact factor: 1.426

4.  The Effects of Ticagrelor Combined with Tirofiban on Coagulation Function, Serum Myocardial Injury Markers, and Inflammatory Factor Levels in Patients with Acute Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Fang Li; Shuhui Wang; Lei Wang; Feng Liu; Zhen Meng; Jia Liu
Journal:  Comput Math Methods Med       Date:  2022-04-28       Impact factor: 2.809

5.  Angiographically Based Direct Implantation of the Bioresorbable Vascular Scaffold in Non-ST Segment Elevation Acute Coronary Syndrome: Feasibility and Outcome.

Authors:  Mahmoud Khaled Nour; Hany Tawfik Fathelbab; Ahmad Hosam Mwafy; Mohamad Ashraf Shawky; Santiago Jesús Camacho Freire; Javier León Jiménez; Jessica Roa Garrido; Antonio Enrique Gómez Menchero; Rosa Cardenal Piris; José Francisco Díaz Fernández; Samir ELhadidy Tawfik
Journal:  Open Access Maced J Med Sci       Date:  2019-08-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.